Search results
Found 1348 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Wearable sensors provide early detection of progression in Parkinson’s Disease
General Innovation Research
11 October 2023
A team of researchers from the University of Oxford has shown for the first time that it is possible to track the progression of Parkinson’s Disease accurately using specially trained machine learning algorithms to analyse data derived from sensor devices worn by patients.
Professor Alan Bernstein appointed as new University of Oxford Director of Global Health
General Research
10 October 2023
Professor Alan Bernstein has been appointed as the new head of Oxford Global Health, which will bring together and showcase the breadth of global health research across the University of Oxford.
New research finds that reducing antibiotic usage in animal feed is not enough to combat antibiotic resistance
General Research
6 October 2023
A new study led by the University of Oxford has found that natural evolution of antibiotic resistance genes has maintained resistance in bacteria despite a reduction in the use of antibiotics. The findings demonstrate the importance of understanding the regulatory evolution of resistance genes to strategically combat AMR. The study has been published in the Journal of the International Society for Microbial Ecology (ISME).
Gene therapy opens new possibilities for treating chronic pain
General Research
6 October 2023
Researchers from the Nuffield Department of Clinical Neurosciences at the University of Oxford, along with colleagues at Cambridge University and Barts and the London School of Medicine and Dentistry, have shown the potential of a new gene therapy approach to silence human sensory neurons (nerve cells) as a means of treating persistent pain. Many current drugs for chronic pain are highly addictive, which makes it important to discover new alternatives.
Oxford researchers develop 3D printing method that shows promise for repairing brain injuries
General Innovation Research
5 October 2023
A breakthrough technique developed by University of Oxford researchers could one day provide tailored repairs for those who suffer brain injuries. The researchers demonstrated for the first time that neural cells can be 3D printed to mimic the architecture of the cerebral cortex. These results have been published today in the journal Nature Communications.
The long road to a new malaria vaccine, told by the scientists behind the breakthrough – podcast
General Research
4 October 2023
Long COVID patients are much more likely to have multiple organ abnormalities
General
4 October 2023
Oxford-Harrington Rare Disease Centre launches pioneering Therapeutics Accelerator to advance inovative treatments for rare diseases
General Innovation Research
3 October 2023
The University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford. The event was hosted by the Oxford-Harrington Rare Disease Centre (OHC), a partnership established in 2019 between the University of Oxford and Harrington Discovery Institute. Attendance at the signing included leaders from OHC, the University of Oxford, the Harrington family, University Hospitals, and Oxford Science Enterprises.
New research endoscopy service launches today
General Research
2 October 2023
The launch of a new endoscopy service at the Oxford Experimental Medicine Clinical Research Facility (EMCRF) will enhance the collection of data for research projects at the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) and across the University of Oxford.
Oxford R21/Matrix-M™ malaria vaccine receives WHO recommendation for use paving the way for global roll-out
Clinical Trials General Research
2 October 2023
The highly effective vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant is critical to reducing over half a million malaria-related deaths annually.
New target identified for pancreatic cancer treatment
General Research
25 September 2023
Researchers at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have found a protein to block the growth of cancer stem-like cells as a possible treatment for pancreatic cancer.
Longer-term organ abnormalities confirmed in some post-hospitalised COVID patients
Coronavirus COVID-19 General Research
25 September 2023
A study looking at the longer-term impact of COVID-19 has found that nearly a third of patients displayed abnormalities in multiple organs five months after infection, some of which have been shown through previous work to be evidence of tissue damage.
Young people’s mental health deteriorated at greater rate during the pandemic
Coronavirus COVID-19 General Research
25 September 2023
Young people’s mental health deteriorated during COVID-19, with higher levels of depression and social, emotional and behavioural difficulties than before the pandemic hit, a comprehensive new study has shown.
Oxford ranked third most intensive science and innovation cluster in the world
General
21 September 2023
The index establishes clusters through analysis of patent-filing activity and scientific article publication, documenting the geographical areas around the world with the highest density of inventors and scientific authors. This data forms part of the latest GII, which is due to be published in full later this month (Sept 27).
Study shows detrimental impact of Long Covid on the education and lives of children and young people
Coronavirus COVID-19 General Research
20 September 2023
New research from the Nuffield Department of Primary Care Health Sciences at the University of Oxford, and the universities of Stirling and Aberdeen funded by the National Institute for Health and Care Research (NIHR), has shone a spotlight on the profound effect Long Covid can have on children and young people’s school experience and wider lives.
Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)
Clinical Trials General Research
19 September 2023
The UK trial is the next step in the development of a vaccine to protect people against MERS – a deadly viral illness with no current vaccines and the potential to cause a pandemic.
When it comes to starting a family, timing is everything
General Research
18 September 2023
The review, conducted jointly with researchers from Oxford University, the Royal Berkshire Hospital in Reading, and the Princess Anne Hospital in Southampton, included seven randomised controlled trials involving 2,464 women or couples who had been trying to conceive.
Continuing inequalities contribute to wide variation in rates of stillbirths and neonatal deaths across UK
General Research
18 September 2023
The MBRRACE-UK Collaboration, jointly led by Nuffield Department of Population Health’s National Perinatal Epidemiology Unit (NPEU) and the University of Leicester’s The Infant Mortality and Morbidity Studies (TIMMS) research group, has published a ‘State of the Nation’ report on perinatal deaths in babies born in the UK in 2021.
First volunteers receive vaccine for Crimean-Congo haemorrhagic fever in Oxford clinical trial
Clinical Trials General Research
13 September 2023
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time. Launched on the 4th of August 2023, the clinical trial of the ChAdOx2 CCHF vaccine aims to confirm its safety and understand how individuals develop immunity following vaccination.